First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer

BACKGROUND: Immunotherapy has made significant advances in the treatment of extensive-stage small-cell lung cancer (ES-SCLC), but data in combination with radiotherapy are scarce. This study aims to assess the safety and efficacy of chemoimmunotherapy combined with thoracic radiotherapy in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lijuan, Yang, Dan, Min, Yanmei, Liao, Anyan, Zhao, Jing, Jiang, Leilei, Dong, Xin, Deng, Wei, Yu, Huiming, Yu, Rong, Zhao, Jun, Shi, Anhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080806/
https://www.ncbi.nlm.nih.gov/pubmed/37024843
http://dx.doi.org/10.1186/s12885-023-10784-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080806/
https://www.ncbi.nlm.nih.gov/pubmed/37024843
http://dx.doi.org/10.1186/s12885-023-10784-8

Ejemplares similares